APA

Qi N., Liu C., Yang H., Shi W., Wang S., Zhou Y., Wei C., Gu F. & Qin Y. (2017). Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress. : Oncotarget.

Chicago

Qi Nan, Liu Chen, Yang Haoran, Shi Wanrong, Wang Shenyi, Zhou Yan, Wei Cai, Gu Fang and Qin Yide. 2017. Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress. : Oncotarget.

Harvard

Qi N., Liu C., Yang H., Shi W., Wang S., Zhou Y., Wei C., Gu F. and Qin Y. (2017). Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress. : Oncotarget.

MLA

Qi Nan, Liu Chen, Yang Haoran, Shi Wanrong, Wang Shenyi, Zhou Yan, Wei Cai, Gu Fang and Qin Yide. Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress. : Oncotarget. 2017.